Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysisCheng Xue, Chenggang Xu, Chenchen Zhou et al.|Clinical Kidney Journal|2020Cited by 52